This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Prostate Cancer

Conferences

Recent Abstracts
WCE 2016: Lost in the Wilderness: Kidney Stone Follow-up in an Urban Hospital - Session Highlights November 16, 2016
WCE 2016: Retroperitoneoscopic Radical Nephrectomy With Thormbectomy From Inferior Vena Cava - Session Highlights November 13, 2016
WCE 2016: Bench-Top Feasibility Testing of a Novel Percutaneous Renal Access Technique: The Laser Direct Alignment Radiation Reduction Technique (DARRT). - Session Highlights November 13, 2016
WCE 2016: The Use of Google GLASS in Surgery - Session Highlights November 12, 2016
WCE 2016: Preoperative and Operative Variables Predict Which Patients Can Be Discharged Without Admission After Percutaneous Ablation of RCC - Session Highlights November 11, 2016
WCE 2016: Precise Characterization and Three-Dimensional Reconstruction of the Autonomic Nerve Distribution of the Human Ureter - Session Highlights November 10, 2016
WCE 2016: Basic Research - Urolithiasis - Benign Urology- Session Highlights November 10, 2016
WCE 2016: Characterization of Urolithiasis Using CT Analysis with Abdomen and Bone Window – Session Highlights November 10, 2016
WCE 2016: MIC-KEY Vesicostomy Button: Endoscopic Insertion is Superior November 10, 2016
SIU Congress 2016: Effect of Gonadotrophin-Releasing Hormone Analogue-Induced Follicle-Stimulating Hormone Suppression on Prostate-Specific Antigen Response - Poster October 24, 2016
SIU Congress 2016: Bladder cancer: Frailty as a predictor of complications in older patients undergoing radical cystectomy - Session Highlights October 24, 2016
SIU Congress 2016: Reclassification in patients candidates for focal therapy: correlation between transrectal biopsy and histology of the lesions observed in mpMRI on radical prostatectomy specimens. - Session Highlights October 24, 2016
SIU Congress 2016: Prostate cancer: Prospective study on the correlation between MRI and pathology of radical prostatectomy specimens - Session Highlights October 24, 2016
SIU Congress 2016: Bladder cancer: Radical cystectomy in the elderly- is this a safe treatment option? - Session Highlights October 24, 2016
SIU Congress 2016: Bladder cancer: Underutilization of radical cystectomy among elderly patients diagnosed with clinical stage T2 muscle-invasive bladder cancer - Session Highlights October 24, 2016
SIU Congress 2016: Challenging cases in bladder cancer: High grade T1 bladder cancer: BCG immunotherapy and urine biomarkers of response - Session Highlights October 23, 2016
SIU Congress 2016: Is there a good risk muscle invasive bladder cancer? Neoadjuvant chemotherapy for all vs. for high risk only - Session Highlights October 22, 2016
SIU Congress 2016: Is there a good risk muscle invasive bladder cancer? Risk factors associated with understaging - Session Highlights October 22, 2016
SIU Congress 2016: Is there a good risk muscle invasive bladder cancer? Cross sectional and functional imaging with PET for staging - Session Highlights October 22, 2016
SIU Congress 2016: Challenging cases in bladder cancer: High grade T1 bladder cancer: New promising alternatives for patients who fail BCG immunotherapy - Session Highlights October 22, 2016
Page 411 of 507
  • Start
  • Prev
  • 406
  • 407
  • 408
  • 409
  • 410
  • 411
  • 412
  • 413
  • 414
  • 415
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free